Celecoxib
- Generic Name
- Celecoxib
- Brand Names
- Celebrex, Elyxyb, Seglentis
- Drug Type
- Small Molecule
- Chemical Formula
- C17H14F3N3O2S
- CAS Number
- 169590-42-5
- Unique Ingredient Identifier
- JCX84Q7J1L
- Background
Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, is a nonsteroidal anti-inflammatory drug (NSAID) which is known for its decreased risk of causing gastrointestinal bleeding compared to other NSAIDS. It is used to manage symptoms of various types of arthritis pain and in familial adenomatous polyposis (FAP) to reduce precancerous polyps in the colon...
- Indication
Celecoxib is indicated for symptomatic treatment of adult osteoarthritis (OA) and adult rheumatoid arthritis (RA). Celecoxib is not a substitute for aspirin for cardiovascular event prophylaxis.
...
- Associated Conditions
- Acute Pain, Ankylosing Spondylitis (AS), Osteoarthritis (OA), Primary Dysmenorrhoea, Rheumatoid Arthritis, Rheumatoid Arthritis, Juvenile, Severe Acute Pain
- Associated Therapies
- -
A Pilot Study Assessing the Treatment Responsiveness of a Novel Osteoarthritis Stiffness Scale
- Conditions
- Interventions
- First Posted Date
- 2018-06-27
- Last Posted Date
- 2020-06-19
- Lead Sponsor
- Bayer
- Target Recruit Count
- 41
- Registration Number
- NCT03570554
- Locations
- 🇺🇸
Radiant Research, Inc., San Antonio, Texas, United States
Different Kinds of Acupuncture Treatment for Knee Osteoarthritis
- Conditions
- Interventions
- First Posted Date
- 2018-06-20
- Last Posted Date
- 2023-06-08
- Lead Sponsor
- Zhejiang Chinese Medical University
- Target Recruit Count
- 360
- Registration Number
- NCT03563690
- Locations
- 🇨🇳
The third affiliated hospital of Zhejiang CMU, Hangzhou, Zhejiang, China
Opioid-Free Shoulder Arthroplasty
- Conditions
- Interventions
- First Posted Date
- 2018-05-30
- Last Posted Date
- 2020-10-14
- Lead Sponsor
- OrthoCarolina Research Institute, Inc.
- Target Recruit Count
- 86
- Registration Number
- NCT03540030
- Locations
- 🇺🇸
OrthoCarolina Research Institute, Charlotte, North Carolina, United States
Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis
- Conditions
- Interventions
- First Posted Date
- 2018-03-22
- Last Posted Date
- 2020-09-22
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 9
- Registration Number
- NCT03473665
- Locations
- 🇺🇸
Columbia University Irving Medical Center, New York, New York, United States
MAST Trial: Multi-modal Analgesic Strategies in Trauma
- First Posted Date
- 2018-03-21
- Last Posted Date
- 2021-06-18
- Target Recruit Count
- 1561
- Registration Number
- NCT03472469
- Locations
- 🇺🇸
The University of Texas Health Science Center at Houston, Houston, Texas, United States
Trial to Evaluate Efficacy and Safety of Combination of Diacerein and Celecoxib Administered in Patients With Knee OA
- First Posted Date
- 2018-01-19
- Last Posted Date
- 2018-02-26
- Lead Sponsor
- Whan-Seok Choi
- Target Recruit Count
- 90
- Registration Number
- NCT03404479
- Locations
- 🇰🇷
Seoul ST. Mary's Hospital, Seoul, Korea, Republic of
🇰🇷Korea University Guro Hospital, Seoul, Korea, Republic of
Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver
- Conditions
- Interventions
- First Posted Date
- 2018-01-18
- Last Posted Date
- 2022-03-02
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 19
- Registration Number
- NCT03403634
- Locations
- 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
Efficacy of Multimodal Analgesia Following Hip Arthroscopy
- Conditions
- Interventions
- First Posted Date
- 2017-11-22
- Last Posted Date
- 2021-10-15
- Lead Sponsor
- Western University, Canada
- Target Recruit Count
- 100
- Registration Number
- NCT03351439
- Locations
- 🇨🇦
Fowler Kennedy Sport Medicine Clinic, London, Ontario, Canada
Radial Extracorporeal Shock Wave Therapy for Chronic Non-specific Low Back Pain
- First Posted Date
- 2017-11-09
- Last Posted Date
- 2017-11-17
- Lead Sponsor
- First Affiliated Hospital of Zhejiang University
- Target Recruit Count
- 150
- Registration Number
- NCT03337607
- Locations
- 🇨🇳
Department of Pain Medicine, First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, China
Toradol v. Celecoxib for Postoperative Pain
- First Posted Date
- 2017-11-06
- Last Posted Date
- 2023-12-07
- Lead Sponsor
- Michael Ulm, MD
- Target Recruit Count
- 170
- Registration Number
- NCT03331315
- Locations
- 🇺🇸
Methodist Hospital System, Memphis, Tennessee, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.